Table 3.
Evaluation of oral dryness in survivors of childhood MB/CNS-PNET, n = 46
| SXI-D score | |
| Median (IQR) | 6 (6–8) |
| Mean ± SD (min–max) | 6.8 ± 1.8 (5–13) |
| CODS score | |
| Median (IQR) | 0 (0–0) |
| Mean ± SD (min–max) | 0.5 ± 1.1 (0–4) |
| Mirror friction test, n (%) | |
| No friction | 41 (89) |
| Friction | 5 (11) |
| Use of medication with dry mouth as possible a side effect, n (%) | 10 (21.7) |
| Use of medication with increased saliva as possible a side effect, n (%) | 3 (6.5) |
MB medulloblastoma, CNS-PNET central nervous system supratentorial primitive neuroectodermal tumor, SXI-D summated xerostomia inventory-Dutch version (scale range 5–15), CODS clinical oral dryness score index (scale range 0–10)